% in the previous quarter due to a slowdown in both of export and tourism sectors. Meanwhile, the private consumption expenditure accelerated in line with rising consumer confidence. In addition, the
Government expenses, in both consumption and investment are still expanding and also an important driving factor of the Thai economy. The government agencies have accelerated the procurement process to be
supply significant portion of our internal electricity use decreasing further operational expenses. 2. Outlook Economic growth accelerated in the third quarter from the near five-year low in the second
Government expenses, in both consumption and investment are still expanding and also an important driving factor of the Thai economy. The government agencies have accelerated the procurement process to be
risk (Stage 3) was 5.6% decreased from 5.8% at the end of previous year, mainly from caution on new loan under the third wave of COVID-19 situation and some of the customers able to repay and accelerated
accelerated write off of NPL from last year. In the end of second quarter of 2021, the consolidated coverage ratio of allowance for expected credit loss to NPL (NPL Coverage ratio) was at 243% increased from
, expenses for personnel compensation and purchases of goods and services. Meanwhile, capital expenditures fell as a result of the high base effect of the government's accelerated budget disbursement last year
transportation agency's disbursement that had accelerated in the previous period. The Company's overall performance in Q2- 2022 was consistent with the overall economic situation. The total revenue in Q2-2022
Thailand and partly driven by the end of Sales and Service Tax (SST) exemption in June 2022 in Malaysia, which created accelerated buying decisions. Cost of sales and services increased in accordance with
Accelerated government spending Source: NESDC, BOT (Apr 2024) Public investmentBillion baht 1Q2022 3Q2022 1Q2023 3Q2023 1Q2024 3Q2024 350 250 150 The Thai economy has not yet fully recovered from the Covid-19